Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regadenoson single-dose safety and pharmacokinetic study in paediatric patients
2019-002615-25Phase 2Unknown
- Sponsor
- GE HealthCare
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of regadenoson, sponsored by GE HealthCare. Status: unknown.
02
Drugs
regadenoson
Beyond the preview
Go deeper on 2019-002615-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002615-25.